Skip to main content
Drug Metabolism and Disposition logoLink to Drug Metabolism and Disposition
. 2026 Jan 3;54(1):100225. doi: 10.1016/j.dmd.2025.100225

Corrigendum to “Upregulation of hepatic flavin-containing monooxygenase 3 by increased corticosterone via glucocorticoid receptor contributes to gestational diabetes mellitus” [Drug Metabolism and Disposition 53 (2025) 100133]

Binxin Chen 1,2, Mingyang Chen 3,4, Xiaoyi Pan 3, Mengru Bai 2, Dongli Sun 1, Huidi Jiang 3, Nengming Lin 2,∗, Zhiyuan Ma 1,∗
PMCID: PMC13095613  PMID: 41485302

In the above article, the Western blot in panel G of Figure 3 incorrectly duplicated panel M in the final published version. Figure 3 with the correct Western blot for panel G is below.

graphic file with name gr1.jpg

In addition, the legends of Figures 2 and 3 require the following changes:

Figure 2 legend should read “primary hepatocytes (K, L) and HepG2 cells (M, N)” in place of “primary hepatocytes (k, l) and HepG2 cells (L, M)” as originally published.

Figure 3 legend should read “Hepatic transcription (L) and protein (M, N)” in place of “Hepatic transcription (I) and protein (J, K)” as originally published.

Contributor Information

Nengming Lin, Email: lnm1013@zju.edu.cn.

Zhiyuan Ma, Email: zhiyuan_ma@zju.edu.cn.


Articles from Drug Metabolism and Disposition are provided here courtesy of American Society for Pharmacology and Experimental Therapeutics

RESOURCES